Search - tctmd.com

Displaying 621 - 640 of 771

Sort: Relevancy | Date

News Features

Top News in Prevention: 2018

Michael O'Riordan

December 28, 2018

News Daily News

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Michael O'Riordan

December 24, 2018

News Daily News

Better TAVR Outcomes With More Experienced Operators: New York Database

Michael O'Riordan

December 12, 2018

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

News Daily News

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Michael O'Riordan

December 03, 2018

News Daily News

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

Michael O'Riordan

November 28, 2018

News Daily News

FDA Touts Increased Oversight of Medical Device Makers

Michael O'Riordan

November 22, 2018

News Conference News AHA 2018

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

Michael O'Riordan

November 12, 2018

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

News Daily News

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

Michael O'Riordan

November 09, 2018

News Daily News

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

Michael O'Riordan

November 06, 2018

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Daily News

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Michael O'Riordan

October 31, 2018

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

News Daily News

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Michael O'Riordan

October 25, 2018

News Daily News

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

Michael O'Riordan

October 25, 2018

News Daily News

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Michael O'Riordan

October 19, 2018

News Daily News

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Michael O'Riordan

October 12, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

News Daily News

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Michael O'Riordan

September 20, 2018

Advertisement

Top News in Prevention: 2018

‘Twas the Night Before Christmas: Holidays Linked to Higher Risk of Acute MI

Better TAVR Outcomes With More Experienced Operators: New York Database

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Benefits of Statins Only Exceed Harms at Higher 10-Year Risk Thresholds, Study Suggests

Less Bivalirudin, Minimal Ultrasound: Survey Highlights Global Transradial Practice Patterns

FDA Touts Increased Oversight of Medical Device Makers

Sit Less, Move More: New Physical Activity Guidelines Stress Movement at All Ages

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Impact of On-site Cardiac Surgery on Clinical Outcomes After Transfemoral TAVR

SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60%

Benefit-Based Approach to Statins Pinpoints One in Six Patients Eligible for Therapy

FDA Approves HeartMate 3 as Destination Therapy in Advanced HF

Weekend Discharge Not Linked to More Readmissions After Cardiac Surgery

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

TAVR Superior to Surgery at Getting High-Risk Patients Home Sooner

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content